Page last updated: 2024-11-03

ranitidine and Neoplasms

ranitidine has been researched along with Neoplasms in 2 studies

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research Excerpts

ExcerptRelevanceReference
"HIF-1 activity in tumors depends on availability of the HIF-1α subunit, the levels of which increase under hypoxic conditions and through activation of oncogenes and/or inactivation of tumor suppressor genes."2.48Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors. ( Choi, HK; Lee, K; Xia, Y, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, E1
Lee, C1
Park, JE1
Seo, JJ1
Cho, M1
Kang, JS1
Kim, HM1
Park, SK1
Lee, K2
Han, G1
Xia, Y1
Choi, HK1

Reviews

1 review available for ranitidine and Neoplasms

ArticleYear
Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
    European journal of medicinal chemistry, 2012, Volume: 49

    Topics: Animals; Antineoplastic Agents; Drug Discovery; Gene Expression Regulation, Neoplastic; Humans; Hypo

2012

Other Studies

1 other study available for ranitidine and Neoplasms

ArticleYear
Structure and property based design, synthesis and biological evaluation of γ-lactam based HDAC inhibitors.
    Bioorganic & medicinal chemistry letters, 2011, Feb-15, Volume: 21, Issue:4

    Topics: Animals; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Membrane Permeability; Compute

2011